Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 382.42M
March 31, 2026 371.70M
December 31, 2025 348.64M
September 30, 2025 411.69M
June 30, 2025 476.27M
March 31, 2025 470.67M
December 31, 2024 462.79M
September 30, 2024 423.98M
June 30, 2024 366.85M
March 31, 2024 250.34M
December 31, 2023 258.70M
September 30, 2023 259.12M
June 30, 2023 244.48M
March 31, 2023 355.69M
December 31, 2022 263.43M
September 30, 2022 172.15M
June 30, 2022 86.59M
March 31, 2022 41.55M
December 31, 2021 41.78M
September 30, 2021 34.22M
June 30, 2021 33.70M
March 31, 2021 4.51M
December 31, 2020 3.922M
September 30, 2020 19.82M
June 30, 2020 41.52M
Date Value
March 31, 2020 65.12M
December 31, 2019 58.32M
September 30, 2019 50.58M
June 30, 2019 46.75M
March 31, 2019 43.78M
December 31, 2018 41.06M
September 30, 2018 38.25M
June 30, 2018 31.29M
March 31, 2018 33.81M
December 31, 2017 37.23M
September 30, 2017 40.46M
June 30, 2017 38.62M
March 31, 2017 39.09M
December 31, 2016 42.24M
September 30, 2016 39.78M
June 30, 2016 32.42M
March 31, 2016 0.732M
December 31, 2015 8.611M
September 30, 2015 -5.992M
June 30, 2015 9.588M
March 31, 2015 16.65M
December 31, 2014 3.453M
September 30, 2014 4.99M
June 30, 2014 -10.32M
March 31, 2014

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Biomerica, Inc. -3.422M
Univec, Inc. -15.55M
Indivior Pharmaceuticals, Inc. -119.51M
Zomedica Corp. -14.80M
Bristol Myers Squibb Co. 11.44B